clinical trial · NCT05399992
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Primary HypercholesterolemiaMixed DyslipidemiaInclisiran
brief summary
This observational prospective study aims to evaluate the LDL-C change and adherence to inclisiran in combination with other lipid lowering therapies or lipid lowering treatments (LLTs) under conditions of routine clinical practice.
started
Sep 12, 2022
primary completion
Nov 23, 2026
completion
Nov 23, 2026
last updated
Nov 6, 2026
detailed description
Patients will be enrolled over a period of 23 months, and followed for up to 24 months to assess for study outcomes.
official title
VICTORION REAL: An International Prospective Real-world Study to Evaluate the LDL-C changE and Adherence to incLisiran in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol